Condition: Thyroid Cancer · Intermediate Risk · Sponsor: Centre Francois Baclesse
This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy
This description comes directly from the study's public registry record.
Renaud CIAPPUCCINI, MD · (33)231455050 · r.ciappuccini@baclesse.unicancer.fr
Always discuss trial participation with your own doctor first.
| CHU Pointe à pitre | Pointe à Pitre, Guadeloupe, France | Not Yet Recruiting |
| Chu Angers | Angers, France | Recruiting |
| Institu de Cancérologie de l'Ouest - Site Angers | Angers, France | Recruiting |
| Bergonié | Bordeaux, France | Recruiting |
| Hôpital saint-André | Bordeaux, France | Recruiting |
| Chu Brest | Brest, France | Recruiting |
| Centre Francois Baclesse | Caen, France | Recruiting |
| Centre Hospitalier Métropôle Savoie | Chambéry, France | Recruiting |
| Centre Jean Perrin | Clermont-Ferrand, France | Recruiting |
| Centre Georges-François Leclerc | Dijon, France | Recruiting |
| Chu Martinique | Fort de France, France | Recruiting |
| Chu Grenoble | Grenoble, France | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04290663